Entropix Strengthens Board with Appointment of Experienced Non-Executive Director
Industry leader Dr David Pears joins the Entropix board and brings a wealth of expert knowledge in relation to specialty chemicals and technology commercialisation. Entropix has recently appointed Dr David Pears to its board as Non-Executive Director. David has over 30 years’ senior experience in the chemical industry, spanning global multinational manufacturers to high-growth, early-stage […]
Entropix Meets with Innovate UK and STFC
Entropix CEO Dr Rob Rule recently hosted Indro Mukerjee (CEO of Innovate UK) and delegates from The Science and Technology Facilities Council (STFC) at our Sci-Tech Daresbury laboratory. It was an opportune meeting to discuss the science behind enzyme engineering and bio catalysis and how the directed evolution of enzymes may help to solve some […]
Entropix Collaborates with the Virtual Engineering Centre (VEC)
Proof-of-Concept Study – Machine Learning for Effective Enzyme Identification and Research Entropix Ltd is an early-stage biotechnology company based at Sci-Tech Daresbury in Cheshire, UK. The enzyme development company is developing enzymes with improved performance using synthetic biology and computational analysis techniques. Entropix supports multiple industry sectors including diagnostics, pharmaceuticals, personal care, food, flavours, fragrances, […]
Entropix Raises Seedcorn Investment to Develop Advanced Enzyme Directed Evolution Technology
Funds will allow for accelerated enzyme development by leveraging directed evolution and machine learning computational techniques. Entropix, an early-stage biotechnology company focused on the directed evolution of enzymes, has completed its first funding round with investment from Deepbridge Capital (Deepbridge). Deepbridge is a growth capital organisation whose portfolio includes growth-focused companies in the technology, life […]